Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Preclinical and clinical studies demonstrate that co-administration of these peptides achieves superior reductions in bodyweight, appetite, and fasting glucose than either agent aloneachieving up to a 17% reduction in bodyweight in non-diabetic individuals and a 15.6% reduction in patients with type 2 diabetes over 2032 weeks
Iacucci, M
Discher DE, Janmey P, Wang YL
The one honest exception: TB-500 works partly by mass-action, so a higher local concentration in the brief window before it disperses is at least plausible
3 Resistance to chemotherapy caused by detoxification by GSH has been postulated, 56 suggesting that there may be possible benefits of selectively decreasing intracellular GSH in tumors to enhance the therapeutic effect of chemotherapy
US$ 24.77
US$ 21.07
US$ 25.32
US$ 20.39
US$ 23.83
US$ 27.43
US$ 20.49
US$ 26.23
